Opiate Dependence Clinical Trial
Official title:
Clinical Efficacy and Serum Proteomic Profiling of Traditional Chinese Medicine, Suan-Zao-Ren Tang, for Sleep Disturbance During Methadone Maintenance: Study Protocol for a Randomized, Double-blind, Placebo-controlled Trial
The purpose of this study is to evaluate the efficacy of Suan-Zao-Ren Tang in improving sleep quality, anxiety, depression, and heroin craving among methadone-maintained persons with sleep complaints.
Background:
Heroin dependence is one of the major health issues worldwide. Methadone Maintenance Therapy
(MMT) is an effective treatment for opioid dependence, but more than three quarters of
persons receiving MMT report sleep complaints. Traditional Chinese Medicine (TCM) is one of
the most common complementary therapies offered to insomnia patients in Taiwan.
Investigators designed a randomized, double-blind, placebo-controlled clinical trial to
evaluate the efficacy of TCM in methadone-maintained persons with sleep disturbance.
Methods/design:
In this study, inclusion criteria are persons receiving MMT for at least one month, more
than 20 years old, complain insomnia with a Pittsburgh Sleep Quality Index (PSQI) of six or
higher. Exclusion criteria include being pregnancy, had serious physical or mental illness,
current use (last 30 days) of TCM, had received any antidepressant or neuroleptic medication
and inability to read and fill out the forms for the study. The patients were separated into
an intervention group (Suan-Zao-Ren Tang, SZRT) and a placebo group for four weeks using a
randomized, double-blind procedure. Outcome measures will be assessed at baseline, 4 weeks
and 8 weeks after receiving medication. PSQI was used to assess sleep quality over the past
30 days, anxiety and depression levels measured by the Beck Anxiety Inventory (BAI) and Beck
Depression Inventory II (BDI-II) were also conducted, heroin craving degree was evaluated by
the change of the visual analog scale (VAS). Serum proteins will be detected using a
proteomics method based on two-dimensional gel electrophoresis, and the specificity of
proteins will confirmed by western blotting. T-test and chi-square tests are used for
statistical analysis.
Discussion:
SZRT is a combination of Semen Zizyphi Spinosae (Suanzaoren), Sclerotium Poriae Cocos
(Fuling), Radix Ligustici Chuanxiong (Chuanxiong), Rhizoma Anemarrhena (Zhimu), and Radix
Glycyrrhizae (Gancao). It was the most commonly prescribed Chinese herbal formula used for
the treatment of insomnia. In the classical literature and previous studies, SZRT was said
to calm the nerves and nourish the blood to eventually bring on a tranquillizing sensation
and improved the quality of sleep without generating significant side effects. In order to
evaluate the efficacy of SZRT for sleep disturbance during methadone maintenance,
investigators designed a randomized, double-blind, placebo-controlled trial and perform the
proteomic-system biology analysis to find the biomarker associated with sleep condition.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Completed |
NCT01690546 -
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
|
Phase 2 | |
Completed |
NCT01442493 -
Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment
|
N/A | |
Completed |
NCT01389167 -
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
|
Phase 3 | |
Completed |
NCT01182402 -
Electronic Compliance Monitoring in Opioid Substitution Treatment
|
N/A | |
Completed |
NCT00634803 -
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
|
Phase 1/Phase 2 | |
Completed |
NCT00987961 -
Linking Hospitalized Injection Drug Users to Buprenorphine
|
Phase 3 | |
Completed |
NCT00566969 -
Cocaine Withdrawal and Pharmacotherapy Response
|
N/A | |
Completed |
NCT00539123 -
Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia
|
N/A | |
Completed |
NCT00577408 -
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
|
Phase 3 | |
Completed |
NCT00757744 -
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
|
Phase 3 | |
Recruiting |
NCT00241930 -
Integrating Buprenorphine Into HIV Treatment
|
Phase 4 | |
Completed |
NCT00218621 -
The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1
|
Phase 2 | |
Completed |
NCT00406484 -
Brief Introductory Therapy for Opioid Dependence
|
Phase 2 | |
Completed |
NCT00580827 -
Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers
|
N/A | |
Completed |
NCT03015597 -
Pilot Study of Contingency Management for Smoking Cessation
|
N/A | |
Completed |
NCT01393392 -
Developing a Smoking Cessation Intervention for Methadone Maintained Smokers
|
Phase 1 | |
Completed |
NCT01416584 -
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
|
N/A | |
Recruiting |
NCT00439049 -
Substance Abuse Pre-Treatment Screening Study
|
||
Withdrawn |
NCT00398008 -
HIV Risk Reduction and Drug Abuse Treatment in Iran
|
Phase 2 |